Industry News
WEHI gets $2m grant for new cancer labs
The Walter and Eliza Hall Institute (WEHI) has received $2 million from the Australian Cancer Research Foundation (ACRF) to fit out two new cancer research laboratories, which will open in late 2012. [ + ]
Cochlear posts $20m loss on recall costs
Cochlear (ASX:COH) has posted a $20.4 million net loss for the first half of this financial year, with earnings impacted by a major recall as well as forex losses. [ + ]
International researcher returns home to lead stem cell initiative
An internationally renowned respiratory specialist will lead a new Centre for Stem Cell Biology and Regenerative Medicine, to be established at The University of Western Australia. [ + ]
New supercomputer to help scientists reach for the stars
A powerful new supercomputer that is 10,000 times faster than an average office computer and big enough to store 2000 years of iTunes music has been installed at The University of Western Australia. [ + ]
Wyatt Technology instruments employed to develop alternative materials to silicone breast implants
Wyatt Technology has announced that Professor Judit E Puskas at the University of Akron has developed a system using its instrumentation that will help to solve a prevalent and controversial material science challenge. The researchers are employing the multidetector system to develop alternative materials to silicone breast implants, as a result of faulty Poly Implant Prothèse (PIP) implants causing global concern about implant safety. [ + ]
Lizards incubated at higher temperatures have enhanced learning performance
A hotter home appears to produce babies with better cognitive abilities - but before you turn up the heater, the research was conducted on the Australian lizard Bassiana duperreyi by researchers from the University of Sydney. [ + ]
Clinuvel files for marketing approval for SCENESSE in Europe
Melbourne-based Clinuvel (ASX:CUV) has applied for the right to market its SCENESSE subdermal treatment in the EU as a treatment for erythropoietic protoporphyria. [ + ]
Book Review: The Genome Generation
Dr Elizabeth Finkel showcases the dramatic changes that have occurred in our understanding of genetics only a decade after the human genome was first sequenced. [ + ]
Alchemia making US inroads with coagulant
Alchemia Limited has revealed it is now selling more than $1.4 million per week worth of its lead drug, fondaparinux, in the US. [ + ]
AusBiotech linked in to the industry network
AusBiotech's two groups on social networking site LinkedIn have grown rapidly in the past year, this week reaching more than 1500 members (combined), cementing their place as the largest networks of their kind for Australian biotechnology and medical technology. [ + ]
State-of-the-art DNA lab for WA Museum
John Day - Minister for Planning; Culture and the Arts; Science and Innovation - has officially opened a new science and research facility at the Western Australian Museum’s Collection and Research Centre. [ + ]
Getting to the heart of microRNAs
A new study reveals the diversity of microRNAs present in the heart, giving some insight into cardiac function and disease. [ + ]
Prima enrols first patient for cancer trial
Sydney's Prima BioMed (ASX:PRR) has enrolled the first participant for an 800-member trial of its CVac ovarian cancer treatment in post-chemotherapy patients. [ + ]
Adam Equipment celebrates 40th anniversary in 2012
Adam Equipment is celebrating its 40th anniversary in 2012. Since its inception, Adam has supplied professionals across a range of industries with balances and scales for various uses, including weighing, counting, price calculating and inventory control. [ + ]
National research cloud will allow for rapid sharing and collaboration on data
The National eResearch Collaboration Tools and Resources (NeCTAR) project is partnering with Australian research institutions to create a national research cloud purpose-built for Australian researchers. [ + ]
